Equillium (EQ US)

Analysis

Health Care • United States

Equillium, Inc. operates as a biotechnology company. The Company develops products for autoimmune and inflammatory disorders. Equillumbio serves patients in the State of California.

Refresh

Focused

No publications yet

There aren’t any podcasts right now

Back to "All"

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00